早期皮质类固醇治疗及其对心室动脉节律失常症的影响 心脏沙丘病的复发:一项为期10年的纵向多中心研究
Akiko Ueda1, Koji Nakagawa2, Koji Miyamoto3
1Division of Advanced Arrhythmia Management, Kyorin University School of Medicine, Tokyo, Japan.
Journal of cardiovascular electrophysiology
|April 16, 2025
概括
早期在心脏型硬化症中使用皮质类固醇可显著减少腹腔动脉节律不良的复发,而不会增加早期事件. 低射出分数与频繁的心律失常有关.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 免疫学 免疫学 免疫学
背景情况:
- 使用皮质类固醇治疗心脏沙丘病 (CS) 中心室动脉节律失常症 (VA) 的管理正在讨论中.
- 这项研究调查了早期类固醇治疗对CS患者VA复发的影响.
研究的目的:
- 评估早期开始使用皮质类固醇对心脏类固醇病的VA复发率的影响.
- 评估类固醇治疗前后VA的频率.
主要方法:
- 对137名心律失常的CS患者进行了回顾性分析.
- 将其分为三组:先前使用类固醇,早期使用类固醇 (60天内) 和不使用或延迟使用类固醇.
- 在81个月的中位随访期内分析VA复发和时间.
主要成果:
- 早期的类固醇开始与更长的VA复发时间相关 (101个月与33个月和17个月相比).
- 在60天后使用皮质类固醇预测可以减少长期VA复发.
- 低左心室喷射分数 (LVEF) 与频繁的VA发作相关.
结论:
- 在CS患者的VA发作后,早期启动皮质类固醇治疗有效地减少了长期复发.
- 类固醇治疗没有提高早期VA发作的发生率.
- 在LVEF降低的患者中,重复的VA更为普遍.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
98
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


